Type
- ARTG (127)
- Prescription medicine registration (38)
- Australian Public Assessment Report (AusPAR) (37)
- Cancellation by sponsor (34)
- Designation or determination (16)
- Laboratory test report (12)
- Prescription medicine decision summary (9)
- Prescription medicine evaluation (4)
- Section 14, TGO91 consent (1)
Results for
"[search-keyword]"
Sponsor content
278 result(s) found, displaying 1 to 10
- Pulmicort 0.5 mg/ml nebuliser suspension (422710)ARTGAustralian Register of Therapeutic Goods (ARTG) information for Pulmicort 0.5 mg/ml nebuliser suspension.
- Pulmicort Respules Budesonide Suspension for Inhalation 2ml: 1mg (422012)ARTGAustralian Register of Therapeutic Goods (ARTG) information for Pulmicort Respules Budesonide Suspension for Inhalation 2ml: 1mg.
- Pulmicort Respules Budesonide Suspension for Inhalation 2ml: 0.5mg (422011)ARTGAustralian Register of Therapeutic Goods (ARTG) information for Pulmicort Respules Budesonide Suspension for Inhalation 2ml: 0.5mg.
- Pulmicort Respules budesonide 0.5 mg/2 mL (416304)ARTGAustralian Register of Therapeutic Goods (ARTG) information for Pulmicort Respules budesonide 0.5 mg/2 mL.
- Pulmicort Respules budesonide 1 mg/2 mL (416305)ARTGAustralian Register of Therapeutic Goods (ARTG) information for Pulmicort Respules budesonide 1 mg/2 mL.
- FELODIPINE AZN ER felodipine 5 mg extended release tablet blister pack (409176)ARTGAustralian Register of Therapeutic Goods (ARTG) information for FELODIPINE AZN ER felodipine 5 mg extended release tablet blister pack.
- FELODIPINE AZN ER felodipine 10 mg extended release tablet blister pack (409178)ARTGAustralian Register of Therapeutic Goods (ARTG) information for FELODIPINE AZN ER felodipine 10 mg extended release tablet blister pack.
- FELODIPINE AZN ER felodipine 2.5 mg extended release tablet blister pack (409175)ARTGAustralian Register of Therapeutic Goods (ARTG) information for FELODIPINE AZN ER felodipine 2.5 mg extended release tablet blister pack.
- AndexxaPrescription medicine decision summaryWe have provisionally approved Andexxa (andexanet alfa) for patients treated with a direct factor Xa inhibitor, when reversal of anticoagulation is needed.
- FORXIGA (AstraZeneca Pty Ltd)Prescription medicine registrationActive ingredients: dapagliflozin propanediol monohydrate.